Akeso Pharmaceuticals, Inc. Patent Application Trends in 2024

From WikiPatents

Revision as of 16:41, 17 July 2024 by Wikipatents (talk | contribs) (Updating Akeso Pharmaceuticals, Inc._Patent_Application_Trends_in_2024)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Contents

1 Akeso Pharmaceuticals, Inc. Patent Filing Activity
2 Akeso Pharmaceuticals, Inc. patent applications in 2024
3 Top 10 Technology Areas
4 Emerging Technology Areas
5 Top Inventors
6 Patent Categories
7 Geographical Distribution of Inventors
8 Geographical Distribution of US Inventors

Akeso Pharmaceuticals, Inc. Patent Filing Activity

Akeso Pharmaceuticals, Inc. patent applications in 2024

Top 10 Technology Areas

C07K16/2818 (No explanation available)
- Count: 2 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
A61P35/00 (No explanation available)
- Count: 2 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
G01N33/577 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
G01N33/68 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
C12N15/62 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
A61P7/06 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
C07K16/46 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
A61K39/395 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
A61P35/02 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
C07K16/468 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)

Emerging Technology Areas

C07K2317/622 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
C07K2317/565 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
C07K2317/31 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
A61K2039/545 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
A61K2039/507 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
C07K16/2863 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
A61K45/06 (No explanation available)
- Count: 1 patents
- Example: 20240199741. USE OF ANTIBODY IN ANTI-TUMOR TREATMENT simplified abstract (Akeso Pharmaceuticals, Inc.)
A61K2039/505 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
C07K16/468 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)
A61P35/02 (No explanation available)
- Count: 1 patents
- Example: 20240010728. ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF simplified abstract (Akeso Pharmaceuticals, Inc.)

Top Inventors

Baiyong LI (1 patent)
Yu XIA (1 patent)
Zhongmin Maxwell WANG (1 patent)
Peng ZHANG (1 patent)
Yu Xia (1 patent)
Zhongmin Maxwell Wang (1 patent)
Baiyong Li (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Akeso Pharmaceuticals, Inc. Inventor States 2024 - Up to June 2024

Retrieved from "http://wikipatents.org/index.php?title=Akeso_Pharmaceuticals,_Inc._Patent_Application_Trends_in_2024&oldid=124631"